Prevalence of antibodies to Onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 1, 2005, Pages 40-43

  Gomez Priego, Alberto ^a,b   Mendoza, Raymundo ^a   De La Rosa, Jorge Luis ^a  

^a SECRETARÍA DE SALUD   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4; IVERMECTIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUATEMALA; HUMAN; INFECTION CONTROL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEXICO; MICROFILARIA; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITIC SKIN DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, HELMINTH; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FILARICIDES; HUMANS; IMMUNOGLOBULIN G; IVERMECTIN; MALE; MEXICO; MIDDLE AGED; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PREVALENCE; TIME FACTORS;

EID: 12544250369     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.1.40-43.2005     Document Type: Article

References (21)

1. Altman, D. A. 1991. Practical statistics for medical research. Chapman and Hall, London, England.
2. Blanks, J., F. O. Richards, F. Beltrán, R. Collins, E. Alvarez, G. Zea-Flores, B. Bauler, R. Cedillos, M. Heisler, D. Brandling-Bennett, W. Baldwin, M. Bayona, R. Klein, and M. Jacox. 1998. The Onchocercosis Elimination Program of the Americas: a history of partnership. Rev. Panam. Salud Públ. 3:367-374.
3. Bradley, J. E., B. M. Atogho, L. Elson, G. R. Stewart, and M. Boussinesq. 1998. A cocktail of recombinant Onchocerca volvulus antigens for serologic diagnosis with the potential to predict the endemicity of onchocercosis infection. Am. J. Trop. Med. Hyg. 59:877-882.
4. Bradley, J. E., K. R. Trenholme, A. J. Gillespie, R. Guderian, V. Titanji, Y. Hong, and L. McReynolds. 1993. A sensitive serodiagnostic test for onchocercosis using a cocktail of recombinant antigens. Am. J. Trop. Med. Hyg. 48:198-204.
5. Cabrera, Z., R. M. E. Parkhouse, K. Forsyth, A. Gómez-Priego, R. Pabón, and L. Yarzábal. 1989. Specific detection of human antibodies to Onchocerca volvulus. Trop. Med. Parasitol. 40:454-459.
6. Dadzie, Y., M. Neira, and D. Hopkins. 2003. Final report of the Conference on the Eradicability of Onchocerciasis. Filaria J. 2:2-134.
7. de-la-Rosa, J. L., P. Alcántara, and D. Correa. 1997. Investigation of cross-reactions against Trichinella spiralis antigens by enzyme-linked immunosorbent assay and enzyme-linked immunoelectrotransfer blot assay in patients with various diseases. Clin. Diagn. Lab. Immunol. 2:122-124.
8. Egwang, T. G., T. H. Duong, C. Nguiri, P. Ngari, S. Everaere, D. Richard-Lenoble, A. A. Gbakima, and M. Komhila. 1994. Evaluation of Onchocerca volvulus-specific IgG4 subclass serology as an index of onchocercosis transmission potential of three Gabonese villages. Clin. Exp. Immunol. 98:401-407.
9. Egwang, T. G., C. Nguiri, M. Kombila, T. H. Duong, and D. Richard-Lenoble. 1993. Elevated antifilarial IgG4 antibody levels in microfilaremic and microfilarodermic Gabonese adults and children. Am. J. Trop. Med. Hyg. 49:132-142.
10. Gómez-Priego, A., L. E. Cruz-Gutiérrez, J. F. Paniagua-Solís, and M. T. Ruenes-Meza. 1993. DIG-ELISA test in Onchocerciasis. Serum antibodies and probability of infection. Arch. Med. Res. 24:353-359.
11. Gómez-Priego, A., J. F. Paniagua-Solís, A. R. Rivas-Alcalá, and M. T. Ruenes-Meza. 1985. Successful application of the diffusion-in-gel-enzyme-linked immunosorbent assay (DIG-ELISA) in Onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 79:159-161.
12. Guzman, G. E., H. O. Akuffo, C. Lavebratt, and R. Luján. 1997. Differential immune response to Onchocerca volvulus: IgG4 antibody responses against antigens differ in Onchocerciasis patients from Guatemala and Ghana. Acta Trop. 63:15-31.
13. Lucius, R., A. Kern, F. Seeber, T. Pogonka, J. Willenbucher, H. R. Taylor, M. Pinder, H. W. Ghalib, H. Schulz-Key, and P. Soboslay. 1992. Specific and sensitive IgG4 immunodiagnosis of Onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (OV33). Trop. Med. Parasitol. 43:139-145.
14. Lucius, R., D. W. Büttner, C. Kirsten, and H. J. Diesfeld. 1986. A study of antigen recognition by Onchocerciasis patients with different clinical form of disease. Parasitology 92:569-580.
15. Maizels, R. M., I. Sutanto, A. Gómez-Priego, J. Lilywhite, and D. A. Denham. 1985. Specificity of surface molecules of adult Brugia parasites: cross-reactivity with antibody from Wuchereria, Onchocerca and other human filarial infections. Trop. Med. Parasitol. 36:233-237.
16. Philipp, M., A. Gómez-Priego, R. M. E. Parkhouse, M. W. Davies, N. W. T. Clark, B. M. Ogilvie, and F. Beltrán-Hernández. 1984. Identification of an antigen of Onchocerca volvulus of possible diagnostic use. Parasitology 89: 295-309.
17. Richards, F. O., Jr., B. Boatin, M. Sauerbrey, and A. Sékétéli. 2001. Control of Onchocerciasis today: status and challenges. Trends Parasitol. 17:558-563.
18. Rodríguez-Pérez, M. A., R. Danis-Lozano, M. H. Rodríguez, and J. E. Bradley. 1999. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico. Trop. Med. Int. Health 4:98-104.
19. Tinoco-Velázquez, I., A. Gómez-Priego, R. Mendoza, and J.-L. de-la-Rosa. 2002. Searching for antibodies against Trichinella spiralis in the sera of patients with fever of unknown cause. Ann. Trop. Med. Parasitol. 96:391-395.
20. Weil, G. J., A. F. Ogunrinade, R. Chandrashekar, and O. O. Kale. 1990. IgG4 subclass antibody serology for Onchocerciasis. J. Infect. Dis. 161:549-554.
21. World Health Organization. 1995. La oncocercosis y su control: informe de un Comité de Expertes de la OMS en lucha contra la oncocercosis. Serie de Informes Técnicos 852. World Health Organization, Geneva, Switzerland.